By Ben Hirschler and Freya Berry LONDON (Reuters) - GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs sold in Western markets, according to three people with direct knowledge of the matter. Chief Executive Andrew Witty said last month that Britain's biggest pharmaceuticals company could dispose of individual medicines or a broader portfolio of older established products. Private equity firms approached by GSK include Advent International, Blackstone and KKR , the sources said, and the drugmaker is being advised by Lazard . Officials at Lazard and the three private equity firms declined to comment.
via Health News Headlines - Yahoo News http://ift.tt/1o08PnQ
No comments:
Post a Comment